© 2009 American Public Health Association DOI: 10.2105/AJPH.2008.153858
Alfred I. Neugut is with the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, and the Division of Oncology, Department of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York. Benjamin Lebwohl is with the Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York. Correspondence: Requests for reprints should be sent to Alfred I. Neugut, MD, PhD, 722 West 168th St, 7th Floor, Room 725, New York, NY 10032 (e-mail: ain1@columia.edu).
Recent reports indicate that close to half of adults aged 50 years and older in the United States have now been screened for colorectal cancer. This rate of screening is usually described as disappointing, and compares unfavorably to the higher rates obtained for other screening tests, such as mammography and Papanicolaou tests,1 with the implication that this state of affairs reflects a failure of the medical and public health systems. After all, only half of all eligible patients are getting a potentially life-saving screening test. Perhaps we are on the wrong track and we need to undertake major reforms in This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||